⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for male

Every month we try and update this database with for male cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate CancerNCT00381836
Prostatic Neopl...
Anemia
Darbepoetin Alf...
18 Years - University of Aarhus
Prostate Cancer Screening: Fostering Informed DecisionsNCT00196807
Prostate Cancer
patient decisio...
40 Years - 70 YearsGeorgetown University
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma PatientsNCT01150318
Thyroid Neoplas...
Administration ...
18 Years - 55 YearsAssistance Publique - Hôpitaux de Paris
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate CancerNCT00381836
Prostatic Neopl...
Anemia
Darbepoetin Alf...
18 Years - University of Aarhus
Study of WST11 in Patients With Localized Prostate CancerNCT00707356
Prostate Cancer
WST11
18 Years - Steba Biotech S.A.
A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary CarcinomaNCT05191927
Thyroid Papilla...
male
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Evaluating Safety and Efficacy of Prostate-sparing Radical CystectomyNCT05792722
Bladder Cancer
Prostate capsul...
Nerve sparing r...
18 Years - Johns Hopkins University
Survey of Testosterone Levels in Male Cancer PatientsNCT00483418
Hypogonadism
18 Years - Beth Israel Medical Center
Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate CancerNCT00667862
Prostate Cancer
Panobinostat
18 Years - Novartis
Understanding Male Breast Cancer: Salah Azaïz Cancer Institute ExperienceNCT03240510
Male Breast Can...
18 Years - Salah Azaïz Cancer Institute
Evaluating Safety and Efficacy of Prostate-sparing Radical CystectomyNCT05792722
Bladder Cancer
Prostate capsul...
Nerve sparing r...
18 Years - Johns Hopkins University
Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male PatientsNCT00922025
Non Small Cell ...
20 Years - AstraZeneca
Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male PatientsNCT00922025
Non Small Cell ...
20 Years - AstraZeneca
Male Breast Cancer: Understanding the Biology for Improved Patient CareNCT01101425
Breast Cancer
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Male Breast Cancer: Understanding the Biology for Improved Patient CareNCT01101425
Breast Cancer
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate CancerNCT00946881
Prostate Cancer
WST 11 -mediate...
18 Years - Steba Biotech S.A.
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate CancerNCT00946881
Prostate Cancer
WST 11 -mediate...
18 Years - Steba Biotech S.A.
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma PatientsNCT01150318
Thyroid Neoplas...
Administration ...
18 Years - 55 YearsAssistance Publique - Hôpitaux de Paris
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: